Skip to main content
SYRE logo
SYRE
(NASDAQ)
Spyre Therapeutics, Inc.
$88.98-- (--)
Loading... - Market loading

Spyre Therapeutics (SYRE) Stock Price & Financial Analysis

Spyre Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$84.68 - $89.18
52-Week High$110.18
52-Week Low$14.51
Open$86.45
Volume776.01K
Average Volume (3M)1.02M
Market Cap30.79B
Shares Outstanding346.05M
Price to Sales (P/S)340.26
Price to Book (P/B)45.90
EV/EBITDA-133.24
Revenue (TTM)90.49M
Net Income (TTM)-179.44M
Free Cash Flow (TTM)-185.80M
EPS (TTM)$-0.87
Profit Margin-198.28%
Operating Margin-255.97%
Return on Equity (ROE)-26.75%
Debt to Equity0.00
50-Day MA$98.08
200-Day MA$61.99
52-Week Change423.41%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Spyre Therapeutics

What is the current stock price for SYRE?

As of the latest trading session, SYRE stock trades at $88.98. The 52-week range is $14.51–$110.18, with a day range of $84.68–$89.18.

What is the P/E ratio for SYRE?

The P/E ratio (Price-to-Earnings) for SYRE is shown in the Key Statistics section. This valuation metric helps compare Spyre Therapeutics, Inc. to industry peers.

Does SYRE pay dividends?

Spyre Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SYRE?

Based on 9 analysts, the consensus for SYRE is Buy.

What is the market cap of SYRE?

Spyre Therapeutics's market capitalization is $30.79B, classifying it as a large-cap company. Spyre Therapeutics operates in the Healthcare sector within the Biotechnology industry.